- Home
- CVRX
CVRX
CVRx Inc.
as 05-17-2024 4:00pm EST
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | MINNEAPOLIS |
| Market Cap: | 168.2M | IPO Year: | 2021 |
| Target Price: | $16.60 | AVG Volume (30 days): | 204.3K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.06 - $33.14 | Next Earning Date: | 04-30-2024 |
| Revenue: | $42,086,000 | Revenue Growth: | 59.59% |
| Revenue Growth (this year): | 43.3% | Revenue Growth (next year): | 37.70% |
Share on Social Networks:
Stock Insider Trading Activity of CVRx Inc. (CVRX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| VERRASTRO PAUL | CVRX | CHIEF MKTG & STRAT OFFICER | Feb 20 '24 | Sell | $21.91 | 2,545 | $55,748.23 | 2,455 | SEC Form 4 |
| JOHNSON & JOHNSON | CVRX | 10% Owner | Feb 16 '24 | Sell | $25.81 | 3,725 | $96,142.25 | 4,099,575 | SEC Form 4 |
Latest CVRx Inc. News
CVRX Breaking Stock News: Dive into CVRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
CVRx Announces Key Senior Leadership Team Hires
Simply Wall St.
17 days ago
CVRx, Inc. (NASDAQ:CVRX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Simply Wall St.
18 days ago
CVRx First Quarter 2024 Earnings: Misses Expectations
Insider Monkey
18 days ago
CVRx, Inc. (NASDAQ:CVRX) Q1 2024 Earnings Call Transcript
Thomson Reuters StreetEvents
19 days ago
Q1 2024 CVRx Inc Earnings Call
GuruFocus.com
19 days ago
CVRx Inc (CVRX) Reports Q1 2024 Results: Revenue Growth Amid Challenges
Associated Press Finance
19 days ago
CVRx: Q1 Earnings Snapshot
GlobeNewswire
19 days ago